RUNX1 and neoplasm: In keeping with previous observations, we observed syn- or metachronous myeloid non-BPDCN neoplasms in a substantial subgroup of the cohort and quite intriguingly RUNX1 mutations with VAFs suggestive of subclonal aberrations in several cases.